0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

The Art of JAMA | 
Carrie A. Butt
JAMA. 2014;312(17):1722-1723. doi:10.1001/jama.2013.279811.

The Art of JAMA | 
Jeanette M. Smith, MD
JAMA. 2014;312(12):1180-1181. doi:10.1001/jama.2013.279741.

Original Investigation | 
Massimo Imazio, MD; Antonio Brucato, MD; Paolo Ferrazzi, MD; et al.
JAMA. 2014;312(10):1016-1023. doi:10.1001/jama.2014.11026.
Includes: Supplemental Content

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;312(9):955-957. doi:10.1001/jama.2014.10644.

Viewpoint | 
Ulrike Bingel, MD, PhD; For the Placebo Competence Team
JAMA. 2014;312(7):693-694. doi:10.1001/jama.2014.8342.

Review | 
Anita Kohli, MD, MS; Ashton Shaffer, BA; Amy Sherman, MD; et al.
JAMA. 2014;312(6):631-640. doi:10.1001/jama.2014.7085.
Includes: CME, Supplemental Content

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;312(6):591. doi:10.1001/jama.2014.9326.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;312(5):477. doi:10.1001/jama.2014.9731.

Original Investigation | 
Wen-Hung Chung, MD, PhD; Wan-Chun Chang, MS; Yun-Shien Lee, PhD; et al.
JAMA. 2014;312(5):525-534. doi:10.1001/jama.2014.7859.
Includes: Supplemental Content

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(4):328. doi:10.1001/jama.2014.9118.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.
JAMA Internal Medicine
Invited Commentary  | 
Tramadol and Hypoglycemia:  One More Thing to Worry About
Lewis S. Nelson, MD; David N. Juurlink, MD, PhD